SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Alpha Tau Announces New Positive Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial: All Patients Treated are Alive with

Alpha Tau Announces New Positive Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Tr

DRTS

Related stories